Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology
JCO Precision Oncology · 2024-03 · (8)
DOI: 10.1200/po.23.00539 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2024-03. Verfasst von Michelle F Jacobs und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Michigan, Ann Arbor, MI. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Neoplastic Syndromes, Hereditary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
PURPOSE Paired tumor-germline sequencing can identify somatic variants for targeted therapy and germline pathogenic variants (GPVs) causative of hereditary cancer/tumor predisposition syndromes. It is unknown how patients/families in pediatric oncology use information about an identified GPV. We assessed recall of germline results and actions taken on the basis of findings. METHODS We completed phone surveys with patients (and/or their parent) with GPVs identified via a single academic medical center's paired tumor-germline sequencing study. Seven hundred forty pediatric (aged 0-25 years) oncology patients were enrolled in this sequencing study between May 2012 and August 2021. Ninety-six participants (13.0%) had at least one GPV identified and were therefore eligible for this survey. The parent/guardian (for patients younger than 18 years or deceased patients) or patients themselves (if 18 years or older) were contacted. Survey topics included germline result recall, experience with genetic counseling, changes to patient's cancer treatment/screening, sharing of results with family members, and lifestyle changes. RESULTS Fifty-three surveys (response rate, 55.2%) were completed between October 2021 and June 2022. Thirty-seven (69.8%) respondents correctly recalled the identified GPV. Discussing results with a genetic counselor ( P = .0001), having a GPV related to the cancer/tumor diagnosis ( P = .002), and non-Hispanic White race/ethnicity ( P = .02) were associated with accurate recall. Twenty-five respondents (47.2%) reported a change in the child's cancer treatment and/or screening recommendations, 17 respondents (32.1%) made a lifestyle change on the basis of the results, and 44 respondents (83.0%) shared results with at least one family member. CONCLUSION While most respondents remembered that a GPV was identified in the patient, some did not recall having a GPV found, and others recalled germline findings incorrectly. Future work may determine patient/family preferences for timing/method of result return to optimize patient recall and use of germline results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
- Rogel Cancer Center, University of Michigan, Ann Arbor, MI.
- Department of Pediatrics, University of Michigan, Ann Arbor, MI.
- Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI.
ORCID-Profile: Michelle F Jacobs, Joshua W Goldman, Sarah Austin, Carl J Koschmann, Rajen J Mody
Förderung
- NINDS NIH HHS
- NHGRI NIH HHS
Zitieren
APA
Jacobs, M. F., Goldman, J. W., Austin, S., Koeppe, E. S., Murad, A. M., Koschmann, C. J., Chinnaiyan, A. M., & Mody, R. J. (2024). Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology. JCO Precision Oncology. https://doi.org/10.1200/po.23.00539
Vancouver
Jacobs MF, Goldman JW, Austin S, Koeppe ES, Murad AM, Koschmann CJ, et al. Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology. JCO Precision Oncology. 2024. doi:10.1200/po.23.00539
BibTeX
@article{Jacobs2024,
author = {Jacobs, Michelle F and Goldman, Joshua W and Austin, Sarah and Koeppe, Erika S and Murad, Andrea M and Koschmann, Carl J and Chinnaiyan, Arul M and Mody, Rajen J},
title = {Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology},
journal = {JCO Precision Oncology},
year = {2024},
number = {8},
doi = {10.1200/po.23.00539}
}
EUVIMED